These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 11102597

  • 1. Oral contraceptives and cardiovascular outcomes: cause or bias?
    Spitzer WO.
    Contraception; 2000 Aug; 62(2 Suppl):3S-9S; discussion 37S-38S. PubMed ID: 11102597
    [Abstract] [Full Text] [Related]

  • 2. The 1995 pill scare revisited: anatomy of a non-epidemic.
    Spitzer WO.
    Hum Reprod; 1997 Nov; 12(11):2347-57. PubMed ID: 9436662
    [Abstract] [Full Text] [Related]

  • 3. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR.
    Lancet; 1997 Jan 11; 349(9045):83-8. PubMed ID: 8996419
    [Abstract] [Full Text] [Related]

  • 4. Bias versus causality: interpreting recent evidence of oral contraceptive studies.
    Spitzer WO.
    Am J Obstet Gynecol; 1998 Sep 11; 179(3 Pt 2):S43-50. PubMed ID: 9753310
    [Abstract] [Full Text] [Related]

  • 5. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
    Carr BR, Ory H.
    Contraception; 1997 May 11; 55(5):267-72. PubMed ID: 9220222
    [Abstract] [Full Text] [Related]

  • 6. Emerging evidence on oral contraceptives and arterial disease.
    Heinemann LA.
    Contraception; 2000 Aug 11; 62(2 Suppl):29S-36S; discussion 37S-38S. PubMed ID: 11102600
    [Abstract] [Full Text] [Related]

  • 7. Third- and second-generation oral contraceptives are associated with similar risk estimates for venous thromboembolism.
    Kaper RF, Norpoth T, Rekers H.
    Eur J Contracept Reprod Health Care; 2000 Mar 11; 5(1):1-15. PubMed ID: 10836658
    [Abstract] [Full Text] [Related]

  • 8. First-time use of newer oral contraceptives and the risk of venous thromboembolism.
    Suissa S, Blais L, Spitzer WO, Cusson J, Lewis M, Heinemann L.
    Contraception; 1997 Sep 11; 56(3):141-6. PubMed ID: 9347203
    [Abstract] [Full Text] [Related]

  • 9. Rebuilding confidence in oral contraceptives: a new imperative in family planning.
    Spitzer WO.
    Br J Clin Pharmacol; 1996 May 11; 41(5):359-63. PubMed ID: 8735675
    [Abstract] [Full Text] [Related]

  • 10. The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
    Lidegaard O.
    Acta Obstet Gynecol Scand; 1997 Mar 11; 76(3):252-60. PubMed ID: 9093141
    [Abstract] [Full Text] [Related]

  • 11. Hemostatic effects of third- and second-generation oral contraceptives: absence of a causal mechanism for a difference in risk of venous thromboembolism.
    Winkler UH.
    Contraception; 2000 Aug 11; 62(2 Suppl):11S-20S; discussion 37S-38S. PubMed ID: 11102598
    [Abstract] [Full Text] [Related]

  • 12. The risks of venous thromboembolic disease among German women using oral contraceptives: a database study.
    Farmer RD, Todd JC, Lewis MA, MacRae KD, Williams TJ.
    Contraception; 1998 Feb 11; 57(2):67-70. PubMed ID: 9589831
    [Abstract] [Full Text] [Related]

  • 13. Modern oral contraceptives and cardiovascular disease.
    Rosenberg L, Palmer JR, Sands MI, Grimes D, Bergman U, Daling J, Mills A.
    Am J Obstet Gynecol; 1997 Sep 11; 177(3):707-15. PubMed ID: 9322646
    [Abstract] [Full Text] [Related]

  • 14. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
    Lewis MA, Heinemann LA, Spitzer WO, MacRae KD, Bruppacher R.
    Contraception; 1997 Sep 11; 56(3):129-40. PubMed ID: 9347202
    [Abstract] [Full Text] [Related]

  • 15. Oral contraceptives and venous thromboembolism: a five-year national case-control study.
    Lidegaard Ø, Edström B, Kreiner S.
    Contraception; 2002 Mar 11; 65(3):187-96. PubMed ID: 11929640
    [Abstract] [Full Text] [Related]

  • 16. The differential risk of oral contraceptives: the impact of full exposure history.
    Lewis MA, MacRae KD, Kühl-Habichl D, Bruppacher R, Heinemann LA, Spitzer WO.
    Hum Reprod; 1999 Jun 11; 14(6):1493-9. PubMed ID: 10359554
    [Abstract] [Full Text] [Related]

  • 17. Venous thromboembolism and combined oral contraceptives: does the type of progestogen make a difference?
    Lawrenson R, Farmer R.
    Contraception; 2000 Aug 11; 62(2 Suppl):21S-28S; discussion 37S-38S. PubMed ID: 11102599
    [Abstract] [Full Text] [Related]

  • 18. Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies.
    Rekers H, Norpoth T, Michaels MA.
    Eur J Contracept Reprod Health Care; 1996 Aug 11; 1(1):21-30. PubMed ID: 9678134
    [Abstract] [Full Text] [Related]

  • 19. Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation "pill scare".
    Heinemann LA, Dinger JC, Assmann A, Minh TD.
    Contraception; 2010 May 11; 81(5):401-7. PubMed ID: 20399946
    [Abstract] [Full Text] [Related]

  • 20. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.
    Heinemann LA, Lewis MA, Thorogood M, Spitzer WO, Guggenmoos-Holzmann I, Bruppacher R.
    BMJ; 1997 Dec 06; 315(7121):1502-4. PubMed ID: 9420491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.